UCB(UCB)
UCB
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $1.12B | $1.18B |
| Low | $1.10B | $1.14B |
| High | $1.14B | $1.22B |
| EBITDA Avg | $377M | $396M |
| Low | $367M | $383M |
| High | $383M | $410M |
| EBIT Avg | $347M | $365M |
| Low | $338M | $353M |
| High | $353M | $377M |
| Net Income Avg | $359M | $395M |
| Low | $353M | $389M |
| High | $366M | $401M |
| EPS Avg | $2.96 | $3.26 |
| Low | $2.90 | $3.19 |
| High | $3.01 | $3.29 |
| Analysts (Rev / EPS) | 2 / 3 | 2 / 3 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $280M | $285M | $287M | $284M | $293M | $301M | $305M |
| Low | $277M | $248M | $271M | $269M | $277M | $285M | $288M |
| High | $284M | $307M | $297M | $294M | $303M | $311M | $315M |
| EBITDA Avg | $94M | $95M | $96M | $95M | $98M | $101M | $102M |
| Low | $93M | $83M | $91M | $90M | $93M | $95M | $96M |
| High | $95M | $103M | $99M | $98M | $101M | $104M | $105M |
| EBIT Avg | $86M | $88M | $89M | $88M | $90M | $93M | $94M |
| Low | $86M | $76M | $84M | $83M | $85M | $88M | $89M |
| High | $88M | $95M | $91M | $91M | $93M | $96M | $97M |
| Net Income Avg | $88M | $92M | $92M | $91M | $97M | $102M | $104M |
| Low | $87M | $89M | $86M | $85M | $90M | $95M | $96M |
| High | $89M | $93M | $96M | $95M | $101M | $107M | $108M |
| EPS Avg | $0.73 | $0.76 | $0.76 | $0.75 | $0.80 | $0.85 | $0.86 |
| Low | $0.72 | $0.74 | $0.71 | $0.70 | $0.74 | $0.79 | $0.80 |
| High | $0.74 | $0.77 | $0.80 | $0.79 | $0.83 | $0.89 | $0.90 |
| Analysts (Rev / EPS) | 3 / 4 | 2 / 3 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |